Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | THRB | P10828 | 1/20 | 0.45 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | CNR1 | P21554 | 1/20 | 0.38 |
| ▸ | CNR2 | P34972 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8205262 | 0.82 | MAPT (0.57) | MAPTL3MBTL1NPC1RAB9ATHRB | |
| SCHEMBL8204958 | 0.74 | MAPT (0.55) | MAPTL3MBTL1NPC1RAB9ATHRB | |
| SCHEMBL17478029 | 0.73 | BCL2L2 (0.38) | MAPTMEN1RECQLKMT2ATDP1 | |
| SCHEMBL6637919 | 0.71 | HRH3 (0.54) | MAPTL3MBTL1NPC1RAB9ATHRB | |
| SCHEMBL21589235 | 0.69 | MAPT (0.49) | MAPTL3MBTL1NPC1RAB9ATHRB | |
| SCHEMBL6636373 | 0.69 | HRH3 (0.61) | MAPTL3MBTL1NPC1RAB9ATHRB | |
| SCHEMBL5672731 | 0.68 | SOAT1 (0.54) | — | |
| SCHEMBL6244092 | 0.67 | TBXAS1 (0.50) | MAPT | |
| SCHEMBL25867877 | 0.67 | LIPG (0.47) | MAPTMEN1ALDH1A1KMT2A | |
| SCHEMBL251097 | 0.66 | LIPG (0.55) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10562913-B2 | Indolizine-based dyes for dye-sensitized solar cell | UNIVERSITY OF MISSISSIPPI (US) | 2020-02-18 | — | — | US | disclosed |
| US-20170226125-A1 | INDOLIZINE-BASED DYES FOR DYE-SENSITIZED SOLAR CELL | UNIVERSITY OF MISSISSIPPI | 2017-08-10 | — | — | US | disclosed |
| WO-2016019182-A1 | INDOLIZINE-BASED DYES FOR DYE-SENSITIZED SOLAR CELL | UNIVERSITY OF MISSISSIPPI (US) | 2016-02-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170226125-A1 | INDOLIZINE-BASED DYES FOR DYE-SENSITIZED SOLAR CELL | INMT, IDO1, IDO2 | MAPT 2311/4885L3MBTL1 4336/4885NPC1 3683/4885 |
| US-10562913-B2 | Indolizine-based dyes for dye-sensitized solar cell | INMT, IDO1, IDO2 | MAPT 2311/4885L3MBTL1 4336/4885NPC1 3683/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.